Commentary

CFIF Opposes State Attorneys General “March-In” Demand on Remdesivir

By CFIF Staff
Thursday, August 06 2020

ALEXANDRIA, VA – This week, a group of state attorneys general issued a joint letter to the United States Department of Health and Human Services (HHS), National Institutes of Health (NIH) and Food and Drug Administration (FDA) demanding that the federal government employ so-called “march-in” rights under the Bayh-Dole Act of 1980 to disregard Gilead Sciences, Inc.’s patent rights on its antiviral drug Remdesivir, or allow their states to do so. The Center for Individual Freedom (CFIF) strongly opposes their demand. “If you seek to bring pharmaceutical…

COVID-19 Lies Go Viral

	Beware of three widely circulating COVID-19-related lies and the partisan motives behind them. These…
	Read more...

Why the Talk of Canceling Debates?

	There are three presidential debates scheduled before the Nov. 3 election. The first will be on Sept.…
	Read more...

The Chicago Gun Myth

	The tragically incompetent mayor of Chicago, Lori Lightfoot, appeared on CNN's "State of the Union"…
	Read more...

"Conservative" George Will Prostrates Himself to Joe Biden

	On July 5, 1987, columnist George Will excoriated aspiring presidential candidate Joe Biden as unfit…
	Read more...

Our Summer of Cultural Suicide

	Cultural suicide used to be a popular diagnosis of why things suddenly just quit. Historians such as…
	Read more...

Using Lifesaving Drugs as a Means of Redistribution

	When lifesaving drugs run low, hospitals have to choose which patients get a scarce drug, while others…
	Read more...

Biden VP Search Underscores Fact He's Too Old To Be President

	An article in Politico got a lot of buzz in Washington, D.C., by reporting that Sen. Kamala Harris might…
	Read more...

CFIF Opposes White House Executive Order Importing Foreign Nations’ Socialized Medicine and Drug Price Controls

ALEXANDRIA, VA – Regrettably, the White House today announced an executive order that effectively…